Skip to main content
Virologica Sinica logoLink to Virologica Sinica
. 2012 Jun 9;27(3):172–178. doi: 10.1007/s12250-012-3242-0

Preparation and identification of anti-rabies virus monoclonal antibodies

Wen-juan Wang 1,2, Xiong Li 3, Li-hua Wang 2, Hu Shan 1, Lei Cao 2, Peng-cheng Yu 2, Qing Tang 2,, Guo-dong Liang 2
PMCID: PMC7091418  PMID: 22684471

Abstract

To provide a foundation for the development of rapid and specific methods for the diagnosis of rabies virus infection, anti-rabies virus monoclonal antibodies were prepared and rabies virus nucleoprotein and human rabies virus vaccine strain (PV strain) were used as immunogens to immunize 6–8 week old female BALB/c mice. Spleen cells and SP2/0 myeloma cells were fused according to conventional methods: the monoclonal cell strains obtained were selected using the indirect immunofluorescence test; this was followed by preparation of monoclonal antibody ascitic fluid; and finally, systematic identification of subclass, specificity and sensitivity was carried out. Two high potency and specific monoclonal antibodies against rabies virus were obtained and named 3B12 and 4A12, with ascitic fluid titers of 1:8000 and 1:10000, respectively. Both belonged to the IgG2a subclass. These strains secrete potent, stable and specific anti-rabies virus monoclonal antibodies, which makes them well suited for the development of rabies diagnosis reagents.

Key words: Rabies virus, Monoclonal antibodies, Specificity, Detection

Footnotes

Foundation items: National Department Public Benefit Research Foundation (201103032); and Pathogens Network Monitoring Technology Research (2008ZX 10004-008)

References

  • 1.Berry J. D., Jones S., Drebot M. A., et al. Development and characterization of neutralizing monoclonal antibody to the SARS-coronavirus. J Virol Methods. 2004;120:67–96. doi: 10.1016/j.jviromet.2004.04.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Camila Z., Luan R. P. A., Paula P. M., et al. Novel monoclonal antibodies that bind to wild and fixed rabies virus strains. J Virol Methods. 2011;175:66–73. doi: 10.1016/j.jviromet.2011.04.019. [DOI] [PubMed] [Google Scholar]
  • 3.Cao L., Tang Q., Tao X. Y., et al. Identification and baculovirus expression of Rabies virus N gene. Chin J Exp Clin Virol. 2010;5(26):351–356. [PubMed] [Google Scholar]
  • 4.de Kruif J., Bakker A. B., Marissen W. E., et al. A human monoclonal antibodies cocktail as a novel component of rabies postexposure prophylaxis. Annu Rev Med. 2007;58:359–368. doi: 10.1146/annurev.med.58.061705.145053. [DOI] [PubMed] [Google Scholar]
  • 5.Harlow E, Lane D. 1988. In: Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory, p219–220.
  • 6.Kohler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975;256(5517):495–497. doi: 10.1038/256495a0. [DOI] [PubMed] [Google Scholar]
  • 7.Lembo T., Niezgoda M., Velasco-Villa A., et al. Evaluation of a direct, rapid immunohistochemical test for rabies diagnosis. Emerg Infect Dis. 2006;12:310–313. doi: 10.3201/eid1202.050812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Liu W. T., Yu P. P., Li Z. H. Purification and Application of the Rabies Viral Monoclonal Antibody. Chin J Vet Drug. 2011;45(4):5–8. [Google Scholar]
  • 9.Meslin F. X., Kaplan M. M., Koprowski H. Laboratory techniques in rabies. Geneva: World Health Organization; 1996. pp. 133–134. [Google Scholar]
  • 10.Muhamuda K., Madhusudana S. N., Ravi V. Use of neutralizing murine monoclonal antibodies to rabies glycoprotein in passive immunotherapy against rabies. Hum Vaccine. 2007;3(5):192–195. doi: 10.4161/hv.3.5.4386. [DOI] [PubMed] [Google Scholar]
  • 11.Wiktor T. J. Monoclonal antibodies against rabies virus produced by somatic cell hybridization: Detection of antigenic variants. Immunology. 1978;75:3938–3942. doi: 10.1073/pnas.75.8.3938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Yu P. C., Lv X. J., Shen X. X., et al. The establishment of a rapid fluorescent focus inhibition test for testing rabies virus neutralizing antibody. Chin J Epidemiol. 2010;31(4):438–441. [PubMed] [Google Scholar]
  • 13.Zhang S. F., Liu Y., Zhang F., et al. Competitive ELISA using a rabies glycoprotein-transformed cell line to semi-quantify rabies neutralizing-related antibodies in dogs. Vaccine. 2009;27:2108–2113. doi: 10.1016/j.vaccine.2009.01.126. [DOI] [PubMed] [Google Scholar]
  • 14.Zhou Y., Li Y. S., Pan F. G., et al. The study of purified methods of mice ascitic fluid IgG McAb. Heilongjiang Anim Sci Vet Med. 2006;10:14–16. [Google Scholar]

Articles from Virologica Sinica are provided here courtesy of Wuhan Institute of Virology, Chinese Academy of Sciences

RESOURCES